Science Explorer Interactive view Map
Company · Montreal · Canada

Aegera Therapeutics (Canada)

aegera.comROR OpenAlex
Research works
42
▲ 115% vs 2013–17
Citations
1.8k
42.9 per fractional work
Top-10% rate
14.8%
record average 16.5%
Open access
40%
world 28%

Not ranked overall: Aegera Therapeutics (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.90× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 6.44× its world share, 1 worksImmunology and Micro…Neuroscience: 1.40× its world share, 0 worksNeuroscienceChemistry: 3.79× its world share, 1 worksChemistryEnvironmental Science: 0.08× its world share, 0 worksEnvironmental ScienceMedicine: 2.69× its world share, 5 worksMedicineEconomics, Econometrics and Finance: 0.57× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.4×. Every wedge is a field page.

Which keywords describe research at Aegera Therapeutics (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Apoptosis, Cell Death, Mitochondria, Reactive Oxygen Species, Bcl-2 Family, TNF Signaling and Regulation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Therapy8▲ 32×9 topics
  2. Apoptosis7▲ 42×9 topics
  3. Cell Death4▲ 52×6 topics
  4. Mitochondria4▲ 54×4 topics
  5. Reactive Oxygen Species4▲ 18×5 topics
  6. Bcl-2 Family3▲ 270×1 topic
  7. TNF Signaling3▲ 270×1 topic
  8. Epidemiology3▲ 1.79×13 topics
  9. Cancer3▲ 4.4×14 topics
  10. Regulation3▲ 10×6 topics
  11. Chemotherapy2▲ 8.0×4 topics
  12. Genetic Variants2▲ 25×2 topics
  13. Mutation2▲ 33×2 topics
  14. Cell Cycle2▲ 89×1 topic
  15. Inflammation2▲ 2.1×13 topics
  16. Inhibitors2▲ 69×2 topics
  17. p532▲ 118×1 topic
  18. Antimicrobial Resistance2▲ 19×3 topics
  19. DNA2▲ 143×1 topic
  20. Topoisomerases2▲ 143×1 topic
  21. Gene Therapy2▲ 15×4 topics
  22. Drug Discovery2▲ 9.9×5 topics
  23. Proteasome Inhibitors2▲ 52×2 topics
  24. Therapy1▲ 16×2 topics
  25. Innate Immunity1▲ 9.3×5 topics
  26. Proteasome1▲ 78×1 topic
  27. Targeted Therapy1▲ 14×3 topics
  28. Ubiquitin1▲ 78×1 topic
  29. Clinical Management1▲ 15×3 topics
  30. Genomic Instability1▲ 22×2 topics
  31. Staphylococcus aureus1▲ 38×2 topics
  32. Surgical Management1▲ 6.2×3 topics
  33. Homologous Recombination1▲ 40×2 topics
  34. Immunotherapy1▲ 4.1×4 topics
  35. MRSA1▲ 77×1 topic
  36. Prognostic Factors1▲ 5.8×4 topics
  37. Staging System1▲ 40×2 topics
  38. Virulence Factors1▲ 14×1 topic
  39. Antiretroviral Therapy1▲ 11×2 topics
  40. HIV Infection1▲ 20×2 topics

Which research topics does Aegera Therapeutics (Canada) publish most on?

By volume in 2022–2025: Cancer-related Molecular Pathways, interferon and immune responses, Cancer Genomics and Diagnostics and Microtubule and mitosis dynamics.

Cancer-related Molecular…1Cancer-related Molecular Pathways: 1 fractional worksinterferon and immune responses: 1 fractional worksCancer Genomics and Diag…1Cancer Genomics and Diagnostics: 1 fractional worksMicrotubule and mitosis …1Microtubule and mitosis dynamics: 1 fractional worksNeuroblastoma Research and Treatments: 0 fractional worksCholangiocarcinoma and Gallbladder Cancer Studies: 0 fractional worksCancer therapeutics and …0Cancer therapeutics and mechanisms: 0 fractional worksLipoproteins and Cardiovascular Health: 0 fractional worksPharmaceutical studies and practices: 0 fractional worksSynthesis and Biological Evaluation: 0 fractional works
OncologyImmunologyCancer ResearchCell Biology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer-related Molecular Pathways Oncology 1 works
  2. 2 interferon and immune responses Immunology 1 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 1 works
  4. 4 Microtubule and mitosis dynamics Cell Biology 1 works
  5. 5 Neuroblastoma Research and Treatments Neurology 0 works
  6. 6 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 0 works
  7. 7 Cancer therapeutics and mechanisms Molecular Biology 0 works
  8. 8 Lipoproteins and Cardiovascular Health Surgery 0 works
  9. 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  10. 10 Synthesis and Biological Evaluation Organic Chemistry 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.9%not open60.1%

World: 28% of research is openly available.

with international co-authors49.3%domestic only50.7%

World: 19% is written across borders.

How has Aegera Therapeutics (Canada)'s research output changed?

Output in 2018–2022 was 115% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Montreal

All research institutions in Montreal

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.